Harrow Balance Sheet Health
Financial Health criteria checks 1/6
Harrow has a total shareholder equity of $70.4M and total debt of $183.2M, which brings its debt-to-equity ratio to 260.1%. Its total assets and total liabilities are $312.2M and $241.8M respectively. Harrow's EBIT is $811.0K making its interest coverage ratio 0. It has cash and short-term investments of $84.5M.
Key information
260.1%
Debt to equity ratio
US$183.17m
Debt
| Interest coverage ratio | 0.04x |
| Cash | US$84.52m |
| Equity | US$70.41m |
| Total liabilities | US$241.75m |
| Total assets | US$312.16m |
Recent financial health updates
These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively
Aug 11
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?
May 12Is Harrow Health (NASDAQ:HROW) A Risky Investment?
Dec 15Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?
Aug 24Recent updates
Harrow: The Bull Thesis Is On Track, But Short-Term Challenges Loom
May 02Harrow's Drug Iheezo Is Off To A Great Start
Feb 19Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity
Jan 30Harrow sells non‑ophthalmic compounding business, terms undisclosed
Oct 05Harrow Health soars ~27% on FDA nod of anesthesia gel for the surface of the eye
Sep 27SRK Capital - Harrow Health: Market Missing The Forest For The Trees
Aug 19These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively
Aug 11Buy Deep Moated, Fast Growing, Superbly Managed Harrow Health Ahead Of New Product Launch
May 23Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?
May 12Is Harrow Health (NASDAQ:HROW) A Risky Investment?
Dec 15Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?
Aug 24Harrow Health prices 8.625% senior notes due 2026
Jun 15Harrow Health: An 8.3% Baby Bond Yield With Low Balance Sheet Leverage
May 28Shareholders Shouldn’t Be Too Comfortable With Harrow Health's (NASDAQ:HROW) Strong Earnings
May 18Harrow Health, Inc. (NASDAQ:HROW) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 11Announcing: Harrow Health (NASDAQ:HROW) Stock Increased An Energizing 299% In The Last Three Years
Mar 08Financial Position Analysis
Short Term Liabilities: HROW's short term assets ($139.5M) exceed its short term liabilities ($49.3M).
Long Term Liabilities: HROW's short term assets ($139.5M) do not cover its long term liabilities ($192.4M).
Debt to Equity History and Analysis
Debt Level: HROW's net debt to equity ratio (140.1%) is considered high.
Reducing Debt: HROW's debt to equity ratio has increased from 58.7% to 260.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HROW has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HROW has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.